ArticleWorld journal of clinical cases2022
Acute moderate to severe ulcerative colitis treated by traditional Chinese medicine: A case report.
Article in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Clinical trajectories after preoperative traditional Chinese medicine in biologic-refractory surgery- intended acute severe ulcerative colitis: an exploratory retrospective case series.Frontiers in immunology · 2026Article
- Optimal traditional Chinese medicine formulas in treating ulcerative colitis: Choose one or take it all?World journal of clinical cases · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUlcerative colitis (UC), also known as chronic nonspecific UC, is an inflammatory bowel disease characterized by diffuse colonic mucosal inflammation. The incidence and prevalence of UC have risen markedly, and the disease seriously affects the quality of life of patients and imposes a great burden on the world health care infrastructure and economy. CASE SUMMARY: Case I describes a 34-year-old female who came to see a doctor because of repeated abdominal pain, diarrhoea and purulent blood for 2 mo. This patient had UC with an initial onset, an active stage and a wide range of lesions. After the poor effect of sulfasalazine and mesalazine, the patient's condition gradually deteriorated, her abdominal pain and bloody stools continued, and anemia occurred. She began treatment with the Chinese medicine Guizhi Dahuang decoction, which was taken orally twice a day, 200 mL each time. After 6 mo of treatment, abdominal pain, diarrhoea, bloody stool and other symptoms disappeared. No abnormality was found by repeat electronic enteroscopye, and the anemia was corrected. The patient's condition did not recur after nearly 4 years of follow-up.
conclusionA series of symptoms in this UC patient significantly improved with the administration of traditional Chinese medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.